Anti-depressants are not working

Prozac and other SSRIs found to be ineffective

Recent research is suggesting that the current crop of antidepressants is often no more effective than placebos or dummy pills. The research, one of the most thorough investigations into the efficacy of new generation antidepressants, known as Selective Serotonin Reuptake Inhibitors (SSRIs), was looking at four commonly-used antidepressants and the clinical trials submitted to gain licensing approval.
The medications reviewed included antidepressants regularly prescribed in the UK, including fluoxetine (Prozac), venlafaxine (Efexor) and paroxetine (Seroxat).
The researchers found that the drugs had little or no more effect than a placebo for mildly depressed patients, and for most people suffering severe depression and that even trials suggesting benefit for severely depressed people did not provide evidence of clear clinical benefit.
The review group, led by Professor Irving Kirsch, from the Department of Psychology at the University of Hull, analysed 47 clinical trials using data released under Freedom of Information rules by the US Food and Drug Administration (FDA).

Professor Kirsch said: “The difference in improvement between patients taking placebos and patients taking antidepressants is not very great. This means that depressed people can improve without chemical treatments. Given these results, there seems little reason to prescribe antidepressant medication to any but the most severely depressed patients, unless alternative treatments have failed to provide a benefit.”

Advice from professionals in the Mental Health field on the back of this research is clear, “It is important that people should not stop taking the anti-depressants immediately, as doing so could lead to severe rebound depression.”
The pharmaceutical companies have argued their products are effective, and said that one study should not be used to cause unnecessary concern for patients.

Warnings in the media about Crystal Meth

We are being warned again about the next big drug problem in the UK

Police chiefs, through the Association of Chief Police Officers (ACPO), and the media are again warning of the possibility of the rise in use of Crystal Meth in the UK. The news reports say that ACPO revealed that 19 crystal meth “factories” had been raided in the last two years across the UK.

In truth there is little evidence of the epidemic that has been promised over the last couple of years. However, complacency is not an option. Whilst we have not seen the levels of use that were feared by many, enforcement agencies and treatment providers across the country need to be vigilant and preparing for a rise in both the availability and use of crystal meth. Strict controls of the precursor chemicals and manufacturing facilities and preparation for the provision of quality services to crystal meth users (and in fact all stimulant users) is vital.

Educating Reefer - A recent survey report from Rethink

Cannabis and Mental Illness

The evidence of a link between cannabis and psychosis/mental health issues is becoming far better established and evidenced in recent years. However, some of the results from this survey indicate a gap in knowledge when one can see that almost one in four people believe that cannabis is better for you than coffee.

Using a public survey, Rethink campaigns examined attitudes to cannabis and suggests that health warnings should be given to the general public.

This document highlights some interesting findings and may be of interest to you.

Cannabis and Mental Health - a recent report

Rethink is the largest national voluntary sector provider of mental health services in the UK. They have a history of campaigning for the rights of people with severe mental illness and their families and carers.